We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

139 hedge funds and large institutions have $1.18B invested in Nektar Therapeutics in 2013 Q2 according to their latest regulatory filings, with 139 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

687% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $1.62M

Holders
139
Holders Change
+139
Holders Change %
–
% of All Funds
4.54%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
139
Increased
–
Reduced
–
Closed
–
Calls
$12.7M
Puts
$1.62M
Net Calls
+$11.1M
Net Calls Change
+$11.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
126
US Bancorp
Minnesota
$116K +$102K +667 New
Ameriprise
127
Ameriprise
Minnesota
$109K +$96.6K +630 New
WAM
128
Wolverine Asset Management
Illinois
$95K +$84.8K +553 New
Teacher Retirement System of Texas
129
Teacher Retirement System of Texas
Texas
$86K +$76.2K +497 New
ST
130
Stifel Trust
Missouri
$81K +$71.6K +467 New
ILIM
131
Irish Life Investment Managers
Ireland
$54.8K +$48.6K +317 New
NC
132
NewSquare Capital
Pennsylvania
$46K +$41K +267 New
NTCOC
133
Northern Trust Company of Connecticut
Connecticut
$44K +$38.8K +253 New
BlackRock
134
BlackRock
New York
$41K +$36.8K +240 New
FANJ
135
Financial Architects (New Jersey)
New Jersey
$35K +$30.7K +200 New
SFSIG
136
San Francisco Sentry Investment Group
California
$28K +$25.2K +164 New
Dimensional Fund Advisors
137
Dimensional Fund Advisors
Texas
$27K +$24.1K +157 New
SCG
138
Strategic Capital Group
Washington
$21K +$18.4K +120 New
LTFS
139
Ladenburg Thalmann Financial Services
Florida
$5K +$4.14K +27 New
2 3 4 5
6

NKTR Hedge Fund Activity: Q2 2013 in Review

139 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2013, worth a combined $1.18B.

Buyers outnumbered sellers: 139 funds opened new NKTR positions and 0 closed out — a net gain of 139 holders — while 0 added to existing stakes and 0 trimmed.

  • 139 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.18B of Nektar Therapeutics stock for Q2 2013.
  • 139 funds opened new Nektar Therapeutics positions in Q2 2013 and 0 closed out, a net change of +139 holders.

Based on aggregated 13F filings for Q2 2013.